Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 3

Results: 38
    1

    Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e528, doi. 10.1634/theoncologist.2019-0751
    By:
    • Bilen, Mehmet Asim;
    • Martini, Dylan J.;
    • Liu, Yuan;
    • Shabto, Julie M.;
    • Brown, Jacqueline T.;
    • Williams, Milton;
    • Khan, Amir I.;
    • Speak, Alexandra;
    • Lewis, Colleen;
    • Collins, Hannah;
    • Kissick, Haydn T.;
    • Carthon, Bradley C.;
    • Akce, Mehmet;
    • Shaib, Walid L.;
    • Alese, Olatunji B.;
    • Pillai, Rathi N.;
    • Steuer, Conor E.;
    • Wu, Christina S.;
    • Lawson, David H.;
    • Kudchadkar, Ragini R.
    Publication type:
    Article
    2
    3
    4
    5

    Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e477, doi. 10.1634/theoncologist.2019-0562
    By:
    • Reyngold, Marsha;
    • Winter, Kathryn A.;
    • Regine, William F.;
    • Abrams, Ross A.;
    • Safran, Howard;
    • Hoffman, John P.;
    • Mowat, Rex B.;
    • Hayes, John P.;
    • Kessel, Ivan L.;
    • DiPetrillo, Thomas;
    • Narayan, Samir;
    • Chen, Yuhchyau;
    • Ben‐Josef, Edgar;
    • Delouya, Guila;
    • Suh, John H.;
    • Meyer, Joshua;
    • Haddock, Michael G.;
    • Feldman, Marvin;
    • Gaur, Rakesh;
    • Yost, Kathleen
    Publication type:
    Article
    6

    Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e589, doi. 10.1634/theoncologist.2019-0527
    By:
    • Schwartzberg, Lee;
    • Navari, Rudolph;
    • Clark‐Snow, Rebecca;
    • Arkania, Ekaterine;
    • Radyukova, Irena;
    • Patel, Kamal;
    • Voisin, Daniel;
    • Rizzi, Giada;
    • Wickham, Rita;
    • Gralla, Richard J.;
    • Aapro, Matti;
    • Roeland, Eric
    Publication type:
    Article
    7

    The Impact of Nonsteroidal Anti‐Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti‐PD‐1 Therapy in Advanced Melanoma.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e602, doi. 10.1634/theoncologist.2019-0518
    By:
    • Wang, Daniel Y.;
    • McQuade, Jennifer L.;
    • Rai, Rajat R.;
    • Park, John J.;
    • Zhao, Shilin;
    • Ye, Fei;
    • Beckermann, Kathryn E.;
    • Rubinstein, Samuel M.;
    • Johnpulle, Romany;
    • Long, Georgina V.;
    • Carlino, Matteo S.;
    • Menzies, Alexander M.;
    • Davies, Michael A.;
    • Johnson, Douglas B.
    Publication type:
    Article
    8
    9

    An Analysis of Recent FDA Oncology Scientific Publications.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. 266, doi. 10.1634/theoncologist.2019-0503
    By:
    • Schneider, Julie A.;
    • Miklos, Andrew C.;
    • Onken, James;
    • Gong, Yutao;
    • Calcagno, Anna Maria;
    • Blumenthal, Gideon M.;
    • Aragon, Richard;
    • Pazdur, Richard
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e439, doi. 10.1634/theoncologist.2019-0493
    By:
    • Hurvitz, Sara A.;
    • Gonçalves, Anthony;
    • Rugo, Hope S.;
    • Lee, Kyung‐Hun;
    • Fehrenbacher, Louis;
    • Mina, Lida A.;
    • Diab, Sami;
    • Blum, Joanne L.;
    • Chakrabarti, Jayeta;
    • Elmeliegy, Mohamed;
    • DeAnnuntis, Liza;
    • Gauthier, Eric;
    • Czibere, Akos;
    • Tudor, Iulia Cristina;
    • Quek, Ruben G.W.;
    • Litton, Jennifer K.;
    • Ettl, Johannes
    Publication type:
    Article
    16
    17
    18
    19
    20

    Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First‐Line Palliative Chemotherapy.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e502, doi. 10.1634/theoncologist.2019-0085
    By:
    • Hong, Soojung;
    • Lee, Ju Hyun;
    • Chun, Eun Kyeong;
    • Kim, Kwang‐Il;
    • Kim, Jin Won;
    • Kim, Se Hyun;
    • Lee, Yun‐Gyoo;
    • Hwang, In Gyu;
    • Kim, Jin Young;
    • Koh, Su‐Jin;
    • Ko, Yoon Ho;
    • Shin, Seong Hoon;
    • Woo, In Sook;
    • Kim, Tae‐Yong;
    • Baek, Ji Yeon;
    • Kim, Hyun Jung;
    • Kim, Hyo Jung;
    • Lee, Myung Ah;
    • Kwon, Jung Hye;
    • Hong, Yong Sang
    Publication type:
    Article
    21

    Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD‐L1 in Gastric Cancer Patients Treated with Either Adjuvant 5‐FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA‐S Trial

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e460, doi. 10.1634/theoncologist.2019-0471
    By:
    • Di Bartolomeo, Maria;
    • Morano, Federica;
    • Raimondi, Alessandra;
    • Miceli, Rosalba;
    • Corallo, Salvatore;
    • Tamborini, Elena;
    • Perrone, Federica;
    • Antista, Maria;
    • Niger, Monica;
    • Pellegrinelli, Alessandro;
    • Randon, Giovanni;
    • Pagani, Filippo;
    • Martinetti, Antonia;
    • Fucà, Giovanni;
    • Pietrantonio, Filippo
    Publication type:
    Article
    22
    23
    24

    Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e578, doi. 10.1634/theoncologist.2019-0453
    By:
    • Henselmans, Inge;
    • Laarhoven, Hanneke W.M.;
    • Maarschalkerweerd, Pomme;
    • Haes, Hanneke C.J.M.;
    • Dijkgraaf, Marcel G.W.;
    • Sommeijer, Dirkje W.;
    • Ottevanger, Petronella B.;
    • Fiebrich, Helle‐Brit;
    • Dohmen, Serge;
    • Creemers, Geert‐Jan;
    • Vos, Filip Y.F.L.;
    • Smets, Ellen M.A.
    Publication type:
    Article
    25
    26

    Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. 259, doi. 10.1634/theoncologist.2019-0403
    By:
    • Brighi, Nicole;
    • Panzuto, Francesco;
    • Modica, Roberta;
    • Gelsomino, Fabio;
    • Albertelli, Manuela;
    • Pusceddu, Sara;
    • Massironi, Sara;
    • Lamberti, Giuseppe;
    • Rinzivillo, Maria;
    • Faggiano, Antongiulio;
    • Spallanzani, Andrea;
    • Ferone, Diego;
    • Prinzi, Natalie;
    • Rossi, Roberta Elisa;
    • Annibale, Bruno;
    • Colao, Anna Maria;
    • Campana, Davide
    Publication type:
    Article
    27

    Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550
    By:
    • Aso, Mari;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Ogasawara, Takahiro;
    • Tsurumi, Kyoji;
    • Ono, Kana;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    28

    Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e398, doi. 10.1634/theoncologist.2018-0883
    By:
    • Zubiri, Leyre;
    • Allen, Ian M.;
    • Taylor, Martin S.;
    • Guidon, Amanda C.;
    • Chen, Steven T.;
    • Schoenfeld, Sara R.;
    • Neilan, Tomas G.;
    • Sise, Meghan E.;
    • Mooradian, Meghan J.;
    • Rubin, Krista M.;
    • Leaf, Rebecca Karp;
    • Parikh, Aparna R.;
    • Faje, Alexander;
    • Gainor, Justin F.;
    • Cohen, Justine V.;
    • Fintelmann, Florian J.;
    • Kohler, Minna J.;
    • Dougan, Michael;
    • Reynolds, Kerry L.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Completing the Translation.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. 183, doi. 10.1634/theoncologist.2019-0650
    By:
    • McCormack, Robert T.;
    • Hayes, Daniel F.
    Publication type:
    Article
    35
    36

    The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e451, doi. 10.1634/theoncologist.2019-0291
    By:
    • Bendell, Johanna C.;
    • Sauri, Tamara;
    • Gracián, Antonio Cubillo;
    • Alvarez, Rafael;
    • López‐López, Carlos;
    • García‐Alfonso, Pilar;
    • Hussein, Maen;
    • Miron, Maria‐Luisa Limon;
    • Cervantes, Andrés;
    • Montagut, Clara;
    • Vivas, Cristina Santos;
    • Bessudo, Alberto;
    • Plezia, Patricia;
    • Moons, Veerle;
    • Andel, Johannes;
    • Bennouna, Jaafar;
    • Westhuizen, Andre;
    • Samuel, Leslie;
    • Rossomanno, Simona;
    • Boetsch, Christophe
    Publication type:
    Article
    37
    38